Skip to content
PubMed This is a summary of 66 peer-reviewed journal articles Updated
Neurology

Neuronal intranuclear inclusion disease (NIID): A Patient Guide

At a Glance

NIID is a rare, progressive genetic disorder that can affect thinking, movement, and automatic body functions. MRI, genetic blood testing, and sometimes a skin biopsy can support diagnosis; there is no cure yet, so coordinated care focuses on symptoms, safety, and independence.

Neuronal Intranuclear Inclusion Disease (NIID) is a rare, progressive genetic disorder that affects the nervous system and multiple organs throughout the body [1]. For many years, it was difficult for doctors to identify because its symptoms vary so widely from person to person, often mimicking more common conditions like Alzheimer’s, Parkinson’s, or even a stroke. At its core, NIID is associated with a specific expansion in the NOTCH2NLC gene, which leads to the formation of tiny protein clumps called inclusions inside the control centers of your cells [2][3].

Living with NIID means navigating a condition that can look different from one month to the next. Some people primarily experience gradual changes in memory and thinking, while others may struggle with tremors, balance issues, or physical weakness in their limbs. A unique feature of the disease is the occurrence of “episodes”—sudden periods of confusion, high fever, or stroke-like symptoms that come and go. Because the condition also affects the autonomic nervous system, it can impact “automatic” body functions like digestion, bladder control, and blood pressure regulation [4][5].

The path to a diagnosis has become much clearer in recent years through a combination of specialized tools. Doctors typically look for a characteristic “ribbon-like” signal on a brain MRI, confirm the genetic expansion through blood work, or perform a small skin biopsy to look for the tell-tale protein inclusions under a microscope [6][7]. While there is currently no cure to stop the underlying genetic process, an early and accurate diagnosis is a powerful step forward. It allows you and your medical team to avoid unnecessary treatments and focus on a proactive, multidisciplinary plan that addresses your specific symptoms [8][9].

Managing NIID is a collaborative effort involving a team of specialists—such as neurologists, physical therapists, and urologists—who work together to maintain your independence and quality of life. While a diagnosis of a rare disease can feel overwhelming, the rapidly growing body of research is providing families with better answers and more targeted ways to manage daily challenges. By focusing on supportive care and monitoring, you and your care team can create a roadmap that honors your goals and provides the specialized attention this complex condition requires [9][10].

Common questions in this guide

What is neuronal intranuclear inclusion disease (NIID)?
NIID is a rare, progressive genetic disorder that affects the nervous system and may involve other organs. It is associated with an expansion in the NOTCH2NLC gene and can cause different symptoms in different people.
What symptoms can NIID cause?
Symptoms may include gradual changes in memory and thinking, tremor, balance problems, and weakness in the limbs. Some people have sudden episodes of confusion, high fever, or stroke-like symptoms. NIID can also affect automatic functions such as digestion, bladder control, and blood-pressure regulation.
How do doctors diagnose NIID?
Doctors may combine a brain MRI, blood-based genetic testing, and a skin biopsy. A ribbon-like MRI signal, an expansion in the NOTCH2NLC gene, and characteristic inclusions in skin cells can support the diagnosis. The tests used depend on the person’s symptoms and clinical evaluation.
Is there a cure for NIID?
There is currently no cure that stops the underlying genetic process in NIID. Treatment focuses on supportive care, symptom management, monitoring, and preserving independence. A multidisciplinary team can adjust the plan as symptoms change.
Which specialists may help manage NIID?
Care may be shared among a neurologist, physical therapist, and urologist, depending on the symptoms and daily challenges involved. The team can work together to support movement, bladder function, independence, and quality of life.
How can I help other healthcare providers understand my NIID diagnosis?
Keep a concise record of your diagnosis, key symptoms, test results, and current care plan to share with healthcare providers. Because NIID is rare, ask your neurologist or care team for a written explanation that can help other clinicians understand your condition.

Get notified when new evidence is published on Neuronal intranuclear inclusion disease.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (10)
  1. 1

    Upstream open reading frame with NOTCH2NLC GGC expansion generates polyglycine aggregates and disrupts nucleocytoplasmic transport: implications for polyglycine diseases.

    Zhong S, Lian Y, Luo W, et al.

    Acta neuropathologica 2021; (142(6)):1003-1023 doi:10.1007/s00401-021-02375-3.

    PMID: 34694469
  2. 2

    A comprehensive study of clinicopathological and genetic features of neuronal intranuclear inclusion disease.

    Liu M, Gao Y, Yuan Y, et al.

    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2023; (44(10)):3545-3556 doi:10.1007/s10072-023-06845-2.

    PMID: 37184590
  3. 3

    The Value of NOTCH2NLC Gene Detection and Skin Biopsy in the Diagnosis of Neuronal Intranuclear Inclusion Disease.

    Pang J, Yang J, Yuan Y, et al.

    Frontiers in neurology 2021; (12()):624321 doi:10.3389/fneur.2021.624321.

    PMID: 34017298
  4. 4

    Clinical features of NOTCH2NLC-related neuronal intranuclear inclusion disease.

    Tian Y, Zhou L, Gao J, et al.

    Journal of neurology, neurosurgery, and psychiatry 2022; (93(12)):1289-1298 doi:10.1136/jnnp-2022-329772.

    PMID: 36150844
  5. 5

    Characteristics of autonomic dysfunction in neuronal intranuclear inclusion disease.

    Zhou L, Tian Y, Zhang S, et al.

    Frontiers in neurology 2023; (14()):1168904 doi:10.3389/fneur.2023.1168904.

    PMID: 37388545
  6. 6

    Neuronal intranuclear inclusion disease in patients with adult-onset non-vascular leukoencephalopathy.

    Liu YH, Chou YT, Chang FP, et al.

    Brain : a journal of neurology 2022; (145(9)):3010-3021 doi:10.1093/brain/awac135.

    PMID: 35411397
  7. 7

    Case Report: Neuronal intranuclear inclusion disease mimicking recurrent stroke in the setting of intracranial stenosis.

    Zhao J, Shen G, Chi L

    Frontiers in medicine 2026; (13()):1838444 doi:10.3389/fmed.2026.1838444.

    PMID: 42245955
  8. 8

    Neuronal intranuclear inclusion disease with subclinical peripheral neuropathy: A case report.

    Sun L, Zhou L, Ren L, et al.

    Medicine 2024; (103(47)):e40636 doi:10.1097/MD.0000000000040636.

    PMID: 39809216
  9. 9

    Levodopa intolerance as a potential clinical red flag for neuronal intranuclear inclusion disease (NIID) in atypical parkinsonism: a case report.

    Zang P, Liu Y, Hao Y

    BMC neurology 2026; (26(1)).

    PMID: 41634634
  10. 10

    Multiple reversible encephalitic attacks: a rare manifestation of neuronal intranuclear inclusion disease.

    Li M, Li K, Li X, et al.

    BMC neurology 2020; (20(1)):125 doi:10.1186/s12883-020-01712-5.

    PMID: 32268889

This NIID guide is for informational purposes only and does not constitute medical advice. Your neurologist and other care-team specialists can interpret your symptoms and test results and tailor care to your situation.